OYMotion

Based in Shanghai, China and founded in 2015, OYMotion Technologies Co. , Ltd. , trading as OYMotion, is a company focusing on the research and development of biometric sensors, intelligent bionic hands, neurorehabilitation exoskeletons, and body-worn intelligent dexterous hands, leveraging AI (artificial intelligence) recognition technology for neural signals, and human-machine neural interface technology. OYMotion's expert team consists of doctors coming from the Department of Hand Surgery of Huashan Hospital and Shanghai University of Traditional Chinese Medicine.

In 2016, the company completed the beta version of gForce EMG Armban. In 2018, it developed version V0. 9 of OHand bionic hand. In March 2026, OYMotion raised CNY 150 million in series C funding led by China International Capital Corporation with participation from other investors.

OYMotion's main products include intelligent bionic prosthetics, intelligent rehabilitation training systems, pneumatic finger training system stimulating finger movement, and wearable exoskeleton products with EEG (electroencephalogram) neural interfaces. The company's products are applied to gesture control in AR/VR (augmented reality/virtual reality) scenarios, reconstruction of motion function in patients with stroke and brachial plexus injuries and assisting people with movement disabilities. The company generates revenue by providing intelligent motion controlling and simulating products.